Cardiology Headline News

Elutia Inc. announced the FDA clearance of its antibiotic-eluting bio-envelope designed to prevent postoperative infection, migration and erosion for implanted devices such as pacemakers and defibrillators.

HF is associated with a fourfold increased risk for death and a sixfold to ninefold increased risk for sudden cardiac death, and its direct and indirect costs are estimated to reach $69.8 billion annually in the United States by 2030.

As we enter the second half of 2024, it is important to understand some tax law changes that became effective this year and could affect your retirement savings and tax planning.

Adults with HF who practiced weekly yoga for 1 year had greater improvements in heart health than those receiving medical management alone, according to a poster presented at the European Society of Cardiology’s Heart Failure 2024 meeting.

The AMA House of Delegates adopted several new policies to promote public health at its annual meeting.

Teleflex and its subsidiary Arrow International issued a recall of its intra-aortic balloon catheter kits due to a manufacturing error that may cause the balloon to become overtwisted.

Fewer U.S. adults aged 40 to 75 years are eligible for statin therapy for primary CVD prevention in the new PREVENT risk calculator compared with the older Pooled Cohort Equation, researchers reported.

PHILADELPHIA — Some dietary change may improve cardiometabolic measures beyond weight loss and providers should create a diet that will most benefit each individual with obesity, according to a speaker.

The AMA adopted policies to protect patients’ access to necessary health care in a variety of ways at its annual meeting.

BOSTON — Lowering cardiovascular risk for people with type 2 diabetes requires effort from far beyond the clinician’s office, leveraging creative community partnerships that address social determinants of health, according to a speaker.